- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02699814
H3: Healthy Minds, Healthy Children, Healthy Chicago Project Evaluation (H3)
The goal of this project is to develop and pilot test a community-based integrated care model to improve the prevention, early detection and treatment of child mental health problems that is replicable, effective, and sustainable. Project procedures include child mental health screening, on-site brief mental health interventions, referral to specialty mental health, use of co-located child psychiatrist, detection of need for primary care in specialty mental health program. Subjects will be enrolled for 1 year, with interviews at baseline and 3, 6 and 12 months.
Dr. Bonnie Zima at UCLA has been contracted by the project funder to design and implement the evaluation of the project, which includes developing data collection procedures, training staff on implementation of data collection workflow, coordinating with sites to ensure evaluation design and IRB protocols are followed, and coordinating with both study sites to verify data reliability.
Some potential anticipated risks include being uncomfortable answering questions associated with the measures used in the study, and although unlikely, someone may access participant information that is confidential. Some benefits include helping to find ways to improve how to deliver mental health care for children served in publicly-funded primary care and mental health clinics.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
UCLA is in charge of the evaluation of the H3 project, including evaluation design and overseeing data collection by project sites. UCLA will receive data collected by each site and perform the analysis of the data for the sites to be shared with the Illinois Children's Healthcare Foundation and clinic sites. This study will evaluate an existing intervention, meaning that participation in the evaluation is not required in order to receive H3 services.
The information below is included in the evaluation design document attached in 10.1, 1.0:
The overarching goal of the Healthy Minds, Healthy Children, Healthy Chicago Initiative (H3) is to develop a community-based integrated care model to improve the prevention, early detection and treatment of child mental health problems that is replicable, effective, and sustainable.
The final study design is a longitudinal cohort study of 400 children ages 0-17 years and their families served at the two intervention clinic sites (n=200/site) The study time points are baseline, 3-, 6-, and 12-months.
The data sources are parent and youth report, and clinic administrative data when feasible for the programs to transfer these data following IRB-approved procedures. The unit of analysis is the child. The main proximal (or short term) clinical outcomes are related to the H3 intervention care processes (e.g., brief mental health interventions, referral to specialty mental health care, co-located child psychiatrist). The time period will likely vary by child depending on clinical need, but it is anticipated that most of these care processes will be provided during the early phase when the child and parent is introduced to the new care model. The main distal outcomes (or more long-term) are clinical improvement (e.g., child symptom reduction, improved functioning) and some correspond to the care process delivered (e.g., if parent receives parent training, improvement parenting skills are assessed). The time points for tracking clinical improvement are 3, 6 and 12 months after the baseline interview that is done when the parent and child are enrolled in the evaluation. The independent variables (or factors that may influence care processes and clinical outcomes) are child sociodemographic characteristics (e.g. age, sex, race/ethnicity), psychosocial complexity, and primary caregiver characteristics that the clinic team or Community Advisory Board deemed relevant (e.g., parenting stress, probable depression). Embedded within the description of a child's psychosocial complexity are indicators of social determinants (e.g. exposure to trauma) that may adversely impact a child's development and well-being.
Findings from this evaluation will provide data on the acceptability and feasibility of the H3 care models, as well as early indicators of whether these care models are promising.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Illinois
-
Chicago, Illinois, États-Unis, 60621
- Miles Square Health Center, Englewood
-
Chicago, Illinois, États-Unis, 60622
- Erie Family Health Center, West Town
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- between the ages of 0.0-16.99 years
- speaks Spanish or English
- screens positive for a developmental delay or mental health problem
- referral to the H3 care program by a pediatrician based on clinical judgment
- no prior history of receiving any H3 services in the past year
Exclusion Criteria (based on the child's characteristics):
- 17 years old (to avoid reconsent at 12 month follow-up)
- has previously had H3 services in the past year
- can not speak English or Spanish
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: H3 Parent/Child Dyads
A child is eligible for the H3 partnered evaluation if he or she is: 1) between the ages of 0.0-16.99
years; 2) speaks Spanish or English; 3) screens positive for a developmental delay or mental health problem.
For children in the intervention groups, the additional eligibility criteria are: 1) referral to the H3 care program by a pediatrician based on clinical judgment; and 2) no prior history of receiving any H3 services in the past year.
|
A community-based integrated care model to improve the prevention, early detection and treatment of child mental health problems
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
H3 intervention care processes
Délai: 12 months
|
tracking administration (yes/no) of "brief mental health interventions", "referral to specialty mental health care", "use of co-located child psychiatrist", "detected need for primary care"
|
12 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Mental health functioning
Délai: Baseline, 3, 6 and 12 months
|
PHQ9
|
Baseline, 3, 6 and 12 months
|
Child development
Délai: 12 monthsBaseline, 3, 6 and 12 months
|
Pediatric Symptom Checklist
|
12 monthsBaseline, 3, 6 and 12 months
|
Child functioning
Délai: Baseline, 3, 6 and 12 months
|
Columbia Impairment Scale
|
Baseline, 3, 6 and 12 months
|
Response to trauma and resilience
Délai: Baseline, 3, 6 and 12 months
|
Traumatic Events Screening Inventory
|
Baseline, 3, 6 and 12 months
|
Care process delivered
Délai: Baseline, 3, 6 and 12 months
|
Questionnaire administered at baseline, 3, 6, and 12 months asking parent and child about any care processes that he/she received.
|
Baseline, 3, 6 and 12 months
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Bonnie Zima, MD, MPH, University of California, Los Angeles
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- IRB#15-000757
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Trouble de santé mentale
-
University of Colorado, DenverEunice Kennedy Shriver National Institute of Child Health and Human Development... et autres collaborateursActif, ne recrute pasServices de santé préventifs (PREV HEALTH SERV)États-Unis
-
Queens College, The City University of New YorkRecrutementPublication d'articles soumis à l'American Journal of Public HealthÉtats-Unis
-
Centre Hospitalier Régional Metz-ThionvilleComplété
-
The Royal Ottawa Mental Health CentrePas encore de recrutement
-
The University of Hong KongRetiré
-
Method X Studios LtdGuy's and St. Thomas' CharityComplété
-
Groupe Hospitalier Mutualiste de GrenobleComplétéHandicaps Mental | Handicaps physiquesFrance
-
The University of Hong KongThe Hong Kong Council of Social ServiceComplété
-
The University of Hong KongHong Kong Family Welfare SocietyComplété
Essais cliniques sur H3 Services
-
Sanofi Pasteur, a Sanofi CompanyComplété
-
Sanofi Pasteur, a Sanofi CompanyComplétéVolontaires en bonne santé | Vaccination contre la grippeÉtats-Unis
-
St. Jude Children's Research HospitalRecrutementGlioblastome | Tumeurs du système nerveux central | Gliome de haut grade | Épendymome | Médulloblastome | Gliome diffus de la ligne médiane, mutant H3 K27M | Tumeur tératoïde/rhabdoïde atypiqueÉtats-Unis
-
Beijing Tiantan HospitalRecrutement
-
DT MedTech, LLCRecrutementArthrose Cheville | Arthrose post-traumatique de la cheville | Arthrose de la cheville secondaire à une arthrite inflammatoire (trouble)États-Unis
-
UNC Lineberger Comprehensive Cancer CenterPas encore de recrutementCancer du pancréas | Rechute | Cancer résistantÉtats-Unis
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Tianjin Medical University Cancer Institute and Hospital; Shandong Cancer...RecrutementNeuroblastome récidivant/réfractaire B7-H3 positifChine
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.RecrutementLeucémie myéloïde aiguë récidivante/réfractaireChine
-
Sohag UniversityComplété
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.RecrutementLeucémie myéloïde aiguë récidivante/réfractaireChine